OGN

13.9100.00%
RA

R. Alan B. Ezekowitz

Independent Director

Dr. R. Alan B. Ezekowitz, D.Phil., FAAP, M.D., MBChB, is Board Director of ai3Bio, Inc. Dr. Ezekowitz has been an Independent Director at Organon & Co. since June 2, 2021. He is a Co-founder of Abide Therapeutics and served as its President and Chief Executive Officer between 2011 and 2019. Mr. Ezekowitz served as a Co-founder of Azanta Danmark A/S. He is an Entrepreneur-In-Residence for Cardinal Partners. He served as Chief of Pediatric Service of Massachusetts General Hospital for Children since September 1995 until 2006. He is a pioneer in the field of innate immunity and helped define the role of pattern recognition molecules in first line host defense. He serves as Senior Vice President and Franchise Head of Immunology, Respiratory and Endocrine at Merck Research Laboratories from 2006 to 2011. He also served as chief of Pediatric Services for Partners HealthCare in Boston between 1999 and 2006. He serves as Chairman of the Scientific Advisory Board of Anika Therapeutics. He serves as a Member of Scientific Advisory Board of EntoMed and Codman Company. He served as a Member of Therapeutic Advisory Board at aTyr Pharma Inc. He served as a Director of Partners HealthCare between 2000 and 2006. Dr. Ezekowitz has been a Venture Partner at Third Rock Ventures, LLC, a healthcare venture firm, since 2019 and has served as Entrepreneur in Residence at Cardinal Partners, a venture capital firm, since 2011. He also serves as an advisor to Fidelity’s Select Biotechnology Portfolio and as a consultant to H. Lundbeck A/S. He served on the board of directors of Partners Healthcare System, Inc. between 2000 and 2006 and he was the Charles Wilder Professor of Pediatrics at the Harvard Medical School and Head of the Laboratory of Developmental Immunology between 1995 and 2006. He currently serves on the board of directors of Fulcrum Therapeutics, Inc. In 1998, the R. Alan Ezekowitz Professorship in Pediatrics at the Harvard Medical School was established. He is Director at Massachusetts General Physicians Organization. Mr. Ezekowitz is also the Director of the Laboratory of Developmental Immunology. He served as a Director of Azanta Danmark A/S. He began his independent research and rose to the rank of Associate Professor at the Harvard Medical School and Director of the General Clinical Research Center at Children's Hospital. He began eleven-year tenure at the Children's Hospital in Boston in 1984. He has led a team of investigators over decade that has defined the role of molecules involved in first line or innate immunity. He has focused his attention on the mannose-binding lectin. He has more than 125 publications in major scientific journals. In 2008, Dr. Ezekowitz was honored with the establishment of the R. Alan Ezekowitz Professorship in Pediatrics at Harvard Medical School. Mr. Ezekowitz obtained his Medical Training at the University of Cape Town in South Africa. He went on to the University of Oxford where he obtained his D.Phil. He completed two postdoctoral fellowships at Children's Hospital Boston in the Division of Hematology and Oncology, Oxford University.

公司職務